Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
Pérez-Belmonte et al., BMC Medicine, doi:10.1186/s12916-020-01832-2
https://c19early.org/perezbelmonte.html